US Patent Issued to Thomas Jefferson University on Dec. 30 for "Oligodendrocyte-derived extracellular vesicles for therapy of multiple sclerosis" (Pennsylvania Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,285, issued on Dec. 30, was assigned to Thomas Jefferson University (Philadelphia).

"Oligodendrocyte-derived extracellular vesicles for therapy of multiple sclerosis" was invented by Abdolmohamad Rostami (Gladwyne, Pa.), Giacomo Casella (Philadelphia), Bogoljub Ciric (Philadelphia) and Guang-Xian Zhang (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "In various aspects and embodiments the invention provides a method of treating multiple sclerosis in a subject in need thereof, the method comprising administering to the subject an effective amount of an oligodendrocyte-derived extracellular vesicle."

The patent was filed on June 3, 2020, ...